Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

Trial N/A Completed Nov. 12, 2013

The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography

Trial Phase 2 Completed Nov. 12, 2013

Special Survey on PD Patients With Renal Dysfunction

Trial N/A Completed Nov. 12, 2013

Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects

Trial Phase 1 Completed Nov. 10, 2013

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Trial Phase 4 Completed Nov. 7, 2013

Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease

Trial Phase 3 Completed Nov. 3, 2013

Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease

Trial N/A Completed Oct. 31, 2013

The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations

Trial Phase 2 Withdrawn Oct. 30, 2013

Apolipoprotein D (ApoD) In Human Serum As Marker Of Parkinson's Disease

Trial N/A Unknown Oct. 29, 2013

A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations

Trial Phase 2 Completed Oct. 28, 2013

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Trial Phase 2 Completed Oct. 28, 2013

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist

Trial Phase 3 Completed Oct. 28, 2013

Comfort and Tolerance of Surface Neuro Muscular Electrical Stimulation in Parkinson's Disease.

Trial N/A Unknown Oct. 23, 2013

Freezing of Gait Correction and Fall Prevention: Developing a Real-time Somatosensory Stimulation System

Trial N/A Unknown Oct. 22, 2013

A Retrospective Study of the Effects of Different Parameters on Motor Symptoms of PD in Bilateral STN Stimulation

Trial N/A Completed Oct. 9, 2013

Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease

Trial Phase 4 Completed Sept. 29, 2013

Motor Performance in Parkinson's Disease After High Intensive Exercise or Deep Brain Stimulation

Trial N/A Completed Sept. 23, 2013

Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies

Trial Phase 4 Completed Sept. 19, 2013

Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease

Trial Phase 1 Completed Sept. 19, 2013

Motor Response to Sildenafil in PD

Trial Phase 4 Completed Sept. 12, 2013